Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.

Journal Information

Full Title: Arch Toxicol

Abbreviation: Arch Toxicol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Toxicology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare that they have no conflict of interest. Ethical approvalThis study has been approved by the appropriate local ethics committees and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Consent to participateInformed consent was obtained from all individual participants included in the study. Conflict of interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding Funding for open access publishing: Universidad Málaga/CBUA. This work was supported by grants from the Instituto de Salud Carlos III, cofounded by Fondo Europeo de Desarrollo Regional (FEDER) (contract numbers: PI21/01248, PI19-00883, PT20/00127, UMA18-FEDERJA-194, PY18-3364), and grants from Consejería de Salud de Andalucía cofounded by FEDER (contract numbers: PEMP-0127-2020, PI-0310-2018) and Agencia Española del Medicamento y Productos Sanitarios. M Villanueva-Paz and I Alvarez-Alvarez hold Sara Borrell research contracts from ISCIII (CD21/00198 and CD20/00083, respectively). J Sanabria-Cabrera holds a Juan Rodés research contract from the National System of Health, ISCIII (JR21/00066). JM Pinazo-Bandera holds a Río Hortega research contract from the National System of Health, ISCIII (CM21/00074). H Niu holds a postdoctoral research contract funded by Junta de Andalucía (POSTDOC_21_00780). SCReN and CIBERehd are funded by ISCIII. This publication is based on work from COST Action CA17112—Prospective European Drug-Induced Liver Injury Network, supported by COST (European Cooperation in Science and Technology); www.cost.eu. The funding sources have no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Funding for open access charge: Universidad de Málaga / CBUA."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025